1. Intracellular Staining and Flow Cytometry to Identify Lymphocyte Subsets within Murine Aorta, Kidney and Lymph Nodes in a Model of Hypertension. Laroumanie F, Dale BL, Saleh MA, Madhur MS (2017) J Vis Exp (119)
    › Primary publication · 28190037 (PubMed) · PMC5352305 (PubMed Central)
  2. Inflammatory cytokines regulate renal sodium transporters: how, where, and why? Norlander AE, Madhur MS (2017) Am J Physiol Renal Physiol 313(2): F141-F144
    › Primary publication · 28404590 (PubMed) · PMC5582911 (PubMed Central)
  3. A salt-sensing kinase in T lymphocytes, SGK1, drives hypertension and hypertensive end-organ damage. Norlander AE, Saleh MA, Pandey AK, Itani HA, Wu J, Xiao L, Kang J, Dale BL, Goleva SB, Laroumanie F, Du L, Harrison DG, Madhur MS (2017) JCI Insight 2(13)
    › Primary publication · 28679951 (PubMed) · PMC5499362 (PubMed Central)
  4. Origin of Matrix-Producing Cells That Contribute to Aortic Fibrosis in Hypertension. Wu J, Montaniel KR, Saleh MA, Xiao L, Chen W, Owens GK, Humphrey JD, Majesky MW, Paik DT, Hatzopoulos AK, Madhur MS, Harrison DG (2016) Hypertension 67(2): 461-8
    › Primary publication · 26693821 (PubMed) · PMC4713264 (PubMed Central)
  5. Novel methods for microCT-based analyses of vasculature in the renal cortex reveal a loss of perfusable arterioles and glomeruli in eNOS-/- mice. Perrien DS, Saleh MA, Takahashi K, Madhur MS, Harrison DG, Harris RC, Takahashi T (2016) BMC Nephrol : 24
    › Primary publication · 26936597 (PubMed) · PMC4776352 (PubMed Central)
  6. Linking inflammation and hypertension via LNK/SH2B3. Dale BL, Madhur MS (2016) Curr Opin Nephrol Hypertens 25(2): 87-93
    › Primary publication · 26717315 (PubMed) · PMC4763980 (PubMed Central)
  7. Interleukin-17A Regulates Renal Sodium Transporters and Renal Injury in Angiotensin II-Induced Hypertension. Norlander AE, Saleh MA, Kamat NV, Ko B, Gnecco J, Zhu L, Dale BL, Iwakura Y, Hoover RS, McDonough AA, Madhur MS (2016) Hypertension 68(1): 167-74
    › Primary publication · 27141060 (PubMed) · PMC4900947 (PubMed Central)
  8. Inhibition of Interleukin 17-A but not Interleukin-17F Signaling Lowers Blood Pressure and Reduces End-organ Inflammation in Angiotensin II-induced Hypertension. Saleh MA, Norlander AE, Madhur MS (2016) JACC Basic Transl Sci 1(7): 606-616
    › Primary publication · 28280792 (PubMed) · PMC5337944 (PubMed Central)
  9. Immune activation caused by vascular oxidation promotes fibrosis and hypertension. Wu J, Saleh MA, Kirabo A, Itani HA, Montaniel KR, Xiao L, Chen W, Mernaugh RL, Cai H, Bernstein KE, Goronzy JJ, Weyand CM, Curci JA, Barbaro NR, Moreno H, Davies SS, Roberts LJ, Madhur MS, Harrison DG (2016) J Clin Invest 126(1): 50-67
    › Primary publication · 26595812 (PubMed) · PMC4701546 (PubMed Central)
  10. Immune activation caused by vascular oxidation promotes fibrosis and hypertension. Wu J, Saleh MA, Kirabo A, Itani HA, Montaniel KR, Xiao L, Chen W, Mernaugh RL, Cai H, Bernstein KE, Goronzy JJ, Weyand CM, Curci JA, Barbaro NR, Moreno H, Davies SS, Roberts LJ, Madhur MS, Harrison DG (2016) J Clin Invest 126(4): 1607
    › Primary publication · 27035819 (PubMed) · PMC4811163 (PubMed Central)